Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $1.5 million.

  • Sotera Health's Other Non Operating Income fell 4610.23% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year increase of 1098.31%. This contributed to the annual value of $5.3 million for FY2024, which is 2802.5% down from last year.
  • As of Q3 2025, Sotera Health's Other Non Operating Income stood at $1.5 million, which was down 4610.23% from $5.8 million recorded in Q2 2025.
  • Over the past 5 years, Sotera Health's Other Non Operating Income peaked at $5.8 million during Q2 2025, and registered a low of -$14.3 million during Q1 2021.
  • In the last 5 years, Sotera Health's Other Non Operating Income had a median value of $1.5 million in 2024 and averaged $464000.0.
  • Per our database at Business Quant, Sotera Health's Other Non Operating Income tumbled by 35434.92% in 2021 and then skyrocketed by 5625000.0% in 2022.
  • Sotera Health's Other Non Operating Income (Quarter) stood at -$4000.0 in 2021, then surged by 56250.0% to $2.2 million in 2022, then skyrocketed by 81.3% to $4.1 million in 2023, then crashed by 69.99% to $1.2 million in 2024, then grew by 25.04% to $1.5 million in 2025.
  • Its Other Non Operating Income stands at $1.5 million for Q3 2025, versus $5.8 million for Q2 2025 and -$289000.0 for Q1 2025.